ResMed (RMD) Misses Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $221.97 -0.73%
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.60, $0.07 worse than the analyst estimate of $1.67. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.14 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
